Articles

Medicare coverage will catalyze market competition

While there are significant data and methodological challenges to be overcome, there are better alternatives to simplistically extrapolating from the real-world data on AOM use that is currently available.

The campaign could have saved about 670,000 more lives had the vaccines been distributed equitably, according to a working paper from the USC Schaeffer Center and Brown University.

Children infected with the Omicron variant remained infectious for a median time of three days after testing positive for the virus, according to USC Schaeffer Center and Stanford researchers.

Drug costs can be driven down if market forces are allowed to target those profits, but first everyone needs to know what is being charged, and by whom to whom.

Doctors, pharmacists, and even drug company sales reps are all paid based on performance because it incentivizes desired outcomes.

Applications are now closed.

Paul Ginsburg discusses how for decades, stakeholders have argued about whether competition or regulation should be the approach to constrain health care spending. By having chosen neither, he argues, our nation now finds itself with a much larger challenge. The magnitude of our health care affordability problem cries out for pursuing both competition and regulation.

As a cancer researcher and a health economist, we’ve seen up close through our lab and consulting work the revolution contained in a blood draw. But cancer detection blood tests aren’t built into annual physicals like standard blood tests, and so far they aren’t covered by insurance.

Health Affairs Editor-in-Chief Alan Weil interviews Jack Chapel, a PhD candidate in economics at the USC Dornsife College of Letters, Arts and Sciences, about a new study examining the worsening health and economic trends for Americans with modest resources nearing retirement.